Diquafosol Sodium Eye Drops
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20243334
Indications:
Indicated for dry eye patients with diagnosed corneal and conjunctival epithelial damage associated with tear abnormalities.
Administration:
Generally, 1 drop per eye, 6 times a day.
Specifications:
3%(5ml:150mg)
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.